Evidence map›Paper›PMID 41899506›Full record

ArticleCancers2026

Co-Expression of IL-2 Enhances the Efficacy of FLT3-CAR-γδT Cells in Acute Myeloid Leukemia.

Xiaona Wang, Fengtao You, Yulan Gu, Xiaofei Ma, Licui Jiang, Hai Wu, Gangli An, Xiaopeng Tian, Lin Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaona WangCyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China.
Fengtao YouPersonGen BioTherapeutics (Suzhou) Co., Ltd., Suzhou 215123, China.
Yulan GuCyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China.
Xiaofei MaCyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China.
Licui JiangPersonGen BioTherapeutics (Suzhou) Co., Ltd., Suzhou 215123, China.
Hai WuPersonGen BioTherapeutics (Suzhou) Co., Ltd., Suzhou 215123, China.
Gangli AnCyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China.ORCID 0000-0003-2033-2005
Xiaopeng TianDepartment of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215006, China.
Lin YangCyrus Tang Medical Institute, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou 215123, China.

Funding

Key Research and Development Program of Anhui Province 2023s07020010Major Science and Technology Project of Anhui Province 202203a07020030Priority Academic Program Development of Jiangsu Higher Education Institutions, the Collabo-rative Innovation Major Project Grant No. XYXT- 2015304the National Key R&D Program of China 2022YFC2502700the Natural Science Foundation of China Grant No.81872431the Project of State Key Laboratory of Radiation Medicine and Protection, Soochow University No.GNZ1201803
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AMLCAR-γδT cellsFLT3IL-2IL-7

Identifiers

PMID41899506
PMCPMC13024764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.